Search - tctmd.com

Displaying 161 - 180 of 225

Sort: Relevancy | Date

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

News Conference News TCT 2013

Memories of TCT from the Beginning: Martin B. Leon, MD

October 29, 2013

News Industry News

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

October 29, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Marvin L. Woodall

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

TAVR-Associated Aortic Root Rupture Hazardous but Predictable

Caitlin E. Cox

June 28, 2013

News Daily News

TAVR相关的主动脉根断裂具有危险性但可预测

Caitlin E. Cox

June 28, 2013

News Daily News

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

Caitlin E. Cox

May 17, 2013

News Daily News

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Yael L. Maxwell

May 13, 2013

News Industry News

Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United States

May 08, 2013

News Industry News

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

May 01, 2013

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Industry News

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

October 29, 2012

News Conference News TCT 2012

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

October 26, 2012

News Conference News TCT 2012

DES: The Year in Review

October 23, 2012

Advertisement

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

Memories of TCT from the Beginning: Martin B. Leon, MD

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

Memories of TCT 1988 and Beyond: Marvin L. Woodall

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Studies Zero in on Baseline Factors That Influence TAVR Outcome

TAVR-Associated Aortic Root Rupture Hazardous but Predictable

TAVR相关的主动脉根断裂具有危险性但可预测

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United States

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

DES: The Year in Review

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content